对象：74例妊娠滋养细胞肿瘤患者标本。
目的：探讨总结妊娠滋养细胞肿瘤(GTT)的治疗经验。
Objective To investigate clinic treatment of gestational trophoblastic tumor (GTT).
目的：分析EMACP方案治疗高危、耐药妊娠滋养细胞肿瘤(GTT)的疗效与毒性。
Objective: To investigate the effect of EMA CP regimen on high risk and drug resistant gestational trophoblastic tumors (GTT).
目的探讨采用新的临床分期后，甲氨蝶呤单药初次化疗治疗低危妊娠滋养细胞肿瘤(GTN)的疗效及其影响因素。
Objective to evaluate the effects of primary chemotherapy with single-agent methotrexate (MTX) on low-risk gestational trophoblastic neoplasia (GTN) and the influencing factors thereof.
结论EPS反应属于中间型滋养细胞为主的妊娠滋养细胞疾病，可能为胎盘部位滋养细胞肿瘤的前期病变。
Conclusions EPS is a kind of gestational trophoblastic disease primarily involving IT. It may be a preneoplastic lesion of placental site trophoblastic tumor (PSTT).
结论EPS反应属于中间型滋养细胞为主的妊娠滋养细胞疾病，可能为胎盘部位滋养细胞肿瘤的前期病变。
Conclusions EPS is a kind of gestational trophoblastic disease primarily involving IT. It may be a preneoplastic lesion of placental site trophoblastic tumor (PSTT).
应用推荐